http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022514077-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2022514077-A |
| titleOfInvention | Use of MCM5 as a marker in semen for prostate cancer |
| abstract | The present invention is a method of detecting the presence or absence of prostate cancer in a subject, the step of providing a semen sample obtained from the subject, and detecting at least one biomarker or at least one biomarker. It relates to a method comprising the step of determining the concentration of a marker. The invention also relates to lysis buffers, monoclonal antibodies, and kits that can be used in such methods. [Selection diagram] Fig. 1 |
| priorityDate | 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.